{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:53:22Z","timestamp":1777618402350,"version":"3.51.4"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/j.bmc.2022.116749","type":"journal-article","created":{"date-parts":[[2022,4,14]],"date-time":"2022-04-14T03:23:30Z","timestamp":1649906610000},"page":"116749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Effects of \u03b2-lapachone and \u03b2-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata"],"prefix":"10.1016","volume":"63","author":[{"given":"Daniel","family":"Clemente de Moraes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"do Carmo Freire Ribeiro Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levy","family":"Ten\u00f3rio Sousa Domingos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor","family":"do Valle Pereira Midlej","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ant\u00f4nio","family":"Ferreira-Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2022.116749_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-019-4710-z","article-title":"Antifungal resistance in patients with Candidaemia: a retrospective cohort study","volume":"20","author":"Aldardeer","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.bmc.2022.116749_b0010","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/541340","article-title":"Multidrug resistance: an emerging crisis","volume":"2014","author":"Tanwar","year":"2014","journal-title":"Interdiscip Perspect Infect Dis"},{"key":"10.1016\/j.bmc.2022.116749_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules22060871","article-title":"Natural products as alternative choices for P-glycoprotein (P-gp) inhibition","volume":"22","author":"Dewanjee","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2022.116749_b0020","first-page":"209","article-title":"Epidemiology of candiduria and Candida urinary tract infections in inpatients and outpatients: Results from a 10-year retrospective survey","volume":"72","author":"Gajd\u00e1cs","year":"2019","journal-title":"Cent Eur J Urol"},{"key":"10.1016\/j.bmc.2022.116749_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2019.00352","article-title":"The epidemiology and susceptibility of Candidemia in Jerusalem, Israel","volume":"9","author":"Israel","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.bmc.2022.116749_b0030","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s15010-020-01393-9","article-title":"Epidemiology of candidemia and impact of infectious disease consultation on survival and care","volume":"48","author":"Mohr","year":"2020","journal-title":"Infection"},{"key":"10.1016\/j.bmc.2022.116749_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0202993","article-title":"ABC transportome inventory of human pathogenic yeast Candida glabrata: phylogenetic and expression analysis","volume":"13","author":"Kumari","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bmc.2022.116749_b0040","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1128\/EC.00073-10","article-title":"Genomewide expression profile analysis of the Candida glabrata Pdr1 regulon","volume":"10","author":"Caudle","year":"2010","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.bmc.2022.116749_b0045","doi-asserted-by":"crossref","unstructured":"D. Whaley, S.G., Zhang, Q., Caudle, K.E., Rogers, Relative contribution of the ABC transporters Cdr1, Pdh1, and Snq2 to azole resistance in Candida glabrata, Antimicrob. Agents Chemother. 62 (2018) 1\u20138.","DOI":"10.1128\/AAC.01070-18"},{"key":"10.1016\/j.bmc.2022.116749_b0050","doi-asserted-by":"crossref","unstructured":"P. Wall, G, Montelongo-Jauregui, D., Bonifacio, B.V., Lopez-Ribot, J.L., Uppuluri, Candida albicans biofilm growth and dispersal: contributions to pathogenesis, Curr Opin Microbiol. 52 (2019) 1\u20136. https:\/\/doi.org\/10.1016\/j.physbeh.2017.03.040.","DOI":"10.1016\/j.mib.2019.04.001"},{"key":"10.1016\/j.bmc.2022.116749_b0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmed.2018.00028","article-title":"Candida biofilms: threats, challenges, and promising strategies","volume":"5","author":"Cavalheiro","year":"2018","journal-title":"Front Med"},{"key":"10.1016\/j.bmc.2022.116749_b0060","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1086\/322972","article-title":"Biofilm formation: a clinically relevant microbiological process","volume":"33","author":"Donlan","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2022.116749_b0065","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.mib.2006.10.003","article-title":"How to build a biofilm: a fungal perspective","volume":"9","author":"Blankenship","year":"2006","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.bmc.2022.116749_b0070","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.mycmed.2018.03.004","article-title":"b -lapachone and a -nor-lapachone modulate Candida albicans viability and virulence factors","volume":"28","author":"Moraes","year":"2018","journal-title":"J Mycol Med"},{"key":"10.1016\/j.bmc.2022.116749_b0075","doi-asserted-by":"crossref","unstructured":"D.C. de Moraes, K.M. Cardoso, L.T.S. Domingos, M. do Carmo Freire Ribeiro Pinto, R.Q. Monteiro, A. Ferreira-Pereira, \u03b2-Lapachone enhances the antifungal activity of fluconazole against a Pdr5p-mediated resistant Saccharomyces cerevisiae strain, Brazilian J. Microbiol. (2020). https:\/\/doi.org\/10.1007\/s42770-020-00254-9.","DOI":"10.1007\/s42770-020-00254-9"},{"key":"10.1016\/j.bmc.2022.116749_b0080","doi-asserted-by":"crossref","unstructured":"D.C. Moraes, L.F. Reis de S\u00e1, L.T.S. Domingos, M. do C.F.R. Pinto, R.M. de A. Soares, A. Ferreira-Pereira, Synergistic interactions between \u03b2-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans, Rev. Iberoam. Micol. (2020). https:\/\/doi.org\/10.1016\/j.riam.2020.09.002.","DOI":"10.1016\/j.riam.2020.09.002"},{"key":"10.1016\/j.bmc.2022.116749_b0085","doi-asserted-by":"crossref","unstructured":"E. Lamping, B.C. Monk, K. Niimi, A.R. Holmes, S. Tsao, K. Tanabe, M. Niimi, Y. Uehara, R.D. Cannon, Characterization of Three Classes of Membrane Proteins Involved in Fungal Azole Resistance by Functional Hyperexpression in Saccharomyces cerevisiae \u25a1, 6 (2007) 1150\u20131165. https:\/\/doi.org\/10.1128\/EC.00091-07.","DOI":"10.1128\/EC.00091-07"},{"key":"10.1016\/j.bmc.2022.116749_b0090","doi-asserted-by":"crossref","unstructured":"D.A.S. Rocha, L.F.R. de Sa, A.C.C. Pinto, M. de L. Junqueira, E.M. da Silva, R.M. Borges, A. Ferreira-Pereira, Characterisation of an ABC transporter of a resistant Candida glabrata clinical isolate, Mem. Inst. Oswaldo Cruz. 113 (2018) 1\u20137. https:\/\/doi.org\/10.1590\/0074-02760170484.","DOI":"10.1590\/0074-02760170484"},{"key":"10.1016\/j.bmc.2022.116749_b0095","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1021\/ja01298a029","article-title":"Constitution of lapachol and its derivatives","volume":"58","author":"Hooker","year":"1936","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2022.116749_b0100","doi-asserted-by":"crossref","unstructured":"K. Niimi, D.R.K. Harding, R. Parshot, A. King, D.J. Lun, A. Decottignies, M. Niimi, S. Lin, R.D. Cannon, A. Goffeau, B.C. Monk, Chemosensitization of Fluconazole Resistance in Saccharomyces cerevisiae and Pathogenic Fungi by a D -Octapeptide Derivative, 48 (2004) 1256\u20131271. https:\/\/doi.org\/10.1128\/AAC.48.4.1256.","DOI":"10.1128\/AAC.48.4.1256-1271.2004"},{"key":"10.1016\/j.bmc.2022.116749_b0105","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jtemb.2014.08.001","article-title":"Diphenyl diselenide (PhSe)2 inhibits biofilm formation by Candida albicans, increasing both ROS production and membrane permeability","volume":"29","author":"Rosseti","year":"2015","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.bmc.2022.116749_b0110","doi-asserted-by":"crossref","unstructured":"M. V Keniya, E. Fleischer, A. Klinger, R.D. Cannon, Inhibitors of the Candida albicans Major Facilitator Superfamily Transporter Mdr1p Responsible for Fluconazole Resistance, (2015) 1\u201316. https:\/\/doi.org\/10.1371\/journal.pone.0126350.","DOI":"10.1371\/journal.pone.0126350"},{"key":"10.1016\/j.bmc.2022.116749_b0115","doi-asserted-by":"crossref","unstructured":"L. Figueira, R. De S\u00e1, F.T. Toledo, B.A. De Sousa, A.C. Gon\u00e7alves, A.C. Tessis, E.P. Wendler, J. V Comasseto, A.A. Dos Santos, A. Ferreira-pereira, Synthetic organotelluride compounds induce the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisiae, (2014) 1\u20139. https:\/\/doi.org\/10.1186\/s12866-014-0201-y.","DOI":"10.1186\/s12866-014-0201-y"},{"key":"10.1016\/j.bmc.2022.116749_b0120","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.archoralbio.2004.04.011","article-title":"Biofilm formation of Candida albicans is variably affected by saliva and dietary sugars","volume":"49","author":"Jin","year":"2004","journal-title":"Arch Oral Biol"},{"key":"10.1016\/j.bmc.2022.116749_b0125","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1016\/j.peptides.2011.08.018","article-title":"Antifungal action of human cathelicidin fragment (LL13-37) on Candida albicans","volume":"32","author":"Wong","year":"2011","journal-title":"Peptides"},{"key":"10.1016\/j.bmc.2022.116749_b0130","doi-asserted-by":"crossref","unstructured":"J.A.R. Curvelo, D.C. DE MORAES, C.A. Dos Anjos, M.B. Portela, R.M.A. Soares, Histatin 5 and human lactoferrin inhibit biofilm formation of a fluconazole resistant candida albicans clinical isolate, An. Acad. Bras. Cienc. 91 (2019) 1\u20137. https:\/\/doi.org\/10.1590\/0001-3765201920180045.","DOI":"10.1590\/0001-3765201920180045"},{"key":"10.1016\/j.bmc.2022.116749_b0135","doi-asserted-by":"crossref","unstructured":"P. de A. Machado, P.S. Gomes, V. Midlej, E.S. Coimbra, H.L. de Matos Guedes, PF-429242, a Subtilisin Inhibitor, Is Effective in vitro Against Leishmania infantum, Front. Microbiol. 12 (2021) 1\u201317. https:\/\/doi.org\/10.3389\/fmicb.2021.583834.","DOI":"10.3389\/fmicb.2021.583834"},{"key":"10.1016\/j.bmc.2022.116749_b0140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fmicb.2020.01584","article-title":"Antifungal activity and potential mechanism of panobinostat in combination with fluconazole against Candida albicans","volume":"11","author":"Su","year":"2020","journal-title":"Front Microbiol"},{"key":"10.1016\/j.bmc.2022.116749_b0145","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1021\/acschembio.8b00306","article-title":"Lawsone, juglone, and \u03b2-lapachone derivatives with enhanced mitochondrial-based toxicity","volume":"13","author":"Anaissi-Afonso","year":"2018","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2022.116749_b0150","doi-asserted-by":"crossref","DOI":"10.4172\/2167-7700.1000131","article-title":"The chemotherapeutic effects of lapacho tree extract: \u03b2-lapachone","volume":"03","author":"Kung","year":"2014","journal-title":"Chemother Open Access"},{"key":"10.1016\/j.bmc.2022.116749_b0155","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/1078-0432.CCR-10-1983","article-title":"Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of beta-lapachone for pancreatic cancer therapy","volume":"17","author":"Li","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.bmc.2022.116749_b0160","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.freeradbiomed.2018.11.012","article-title":"Mitochondrial disfunction and ROS production are essential for anti-Trypanosoma cruzi activity of \u03b2-lapachone-derived naphthoimidazoles","volume":"130","author":"Bomba\u00e7a","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.bmc.2022.116749_b0165","doi-asserted-by":"crossref","unstructured":"T.B.C.-P. Antonio Ferreira-Pereira, Luciana Pereira Rangel, Marcio Fritzen, Rosendo Augusto Yunes, Paulo C\u00e9sar Leal, Inhibitory effects of gallic acid ester derivatives on Saccharomyces cerevisiae multidrug resistance protein Pdr5p, 10 (2010) 244\u2013251. https:\/\/doi.org\/10.1111\/j.1567-1364.2010.00603.x.","DOI":"10.1111\/j.1567-1364.2009.00603.x"},{"key":"10.1016\/j.bmc.2022.116749_b0170","doi-asserted-by":"crossref","first-page":"3256","DOI":"10.1128\/AAC.01497-08","article-title":"Curcumin modulates efflux mediated by yeast ABC multidrug transporters and is synergistic with antifungals","volume":"53","author":"Sharma","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2022.116749_b0175","doi-asserted-by":"crossref","first-page":"4834","DOI":"10.1128\/AAC.00344-11","article-title":"The quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicans","volume":"55","author":"Sharma","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2022.116749_b0180","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ejmech.2018.12.044","article-title":"Synthesis of tetrazole derivatives bearing pyrrolidine scaffold and evaluation of their antifungal activity against Candida albicans","volume":"164","author":"\u0141ukowska-chojnacka","year":"2018","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2022.116749_b0185","first-page":"411","article-title":"Flow cytometry for rapid assessment of viability after exposure to a quaternary ammonium compound","volume":"81","author":"Langsrud","year":"1996","journal-title":"J Appl Bacteriol"},{"key":"10.1016\/j.bmc.2022.116749_b0190","article-title":"A review on macroscale and microscale cell lysis methods","volume":"8","author":"Islam","year":"2017","journal-title":"Micromachines"},{"key":"10.1016\/j.bmc.2022.116749_b0195","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1080\/08927014.2016.1216103","article-title":"Anti-biofilm mechanisms of 3,5-di-tert-butylphenol against clinically relevant fungal pathogens","volume":"32","author":"Rathna","year":"2016","journal-title":"Biofouling"},{"key":"10.1016\/j.bmc.2022.116749_b0200","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-35530-0","article-title":"Antifungal and anti-biofilm activity of the first cryptic antimicrobial peptide from an archaeal protein against Candida spp. clinical isolates","volume":"8","author":"Roscetto","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmc.2022.116749_b0205","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19041018","article-title":"Phasor-based endogenous NAD(P)H fluorescence lifetime imaging unravels specific enzymatic activity of neutrophil granulocytes preceding NETosis","volume":"19","author":"Leben","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2022.116749_b0210","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1574-6968.2000.tb09216.x","article-title":"Candida glabrata displays pseudohyphal growth","volume":"189","author":"Csank","year":"2000","journal-title":"FEMS Microbiol Lett"},{"key":"10.1016\/j.bmc.2022.116749_b0215","doi-asserted-by":"crossref","unstructured":"A. Calcagno, E. Bignell, P. Warn, M.D. Jones, D.W. Denning, F.A. M\u00fchlschlegel, T.R. Rogers, K. Haynes, Candida glabrata STE12 is required for wild-type levels of virulence and nitrogen starvation induced filamentation, 50 (2003) 1309\u20131318. https:\/\/doi.org\/10.1046\/j.1365-2958.2003.03755.x.","DOI":"10.1046\/j.1365-2958.2003.03755.x"},{"key":"10.1016\/j.bmc.2022.116749_b0220","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1128\/IAI.71.8.4333-4340.2003","article-title":"Mechanism of fluconazole resistance in Candida albicans biofilms: Phase-specific role of efflux pumps and membrane sterols","volume":"71","author":"Mukherjee","year":"2003","journal-title":"Infect Immun"}],"container-title":["Bioorganic & Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089622001419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:17:49Z","timestamp":1760836669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089622001419"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6]]},"references-count":44,"alternative-id":["S0968089622001419"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116749","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of \u03b2-lapachone and \u03b2-nor-lapachone on multidrug efflux transporters and biofilms of Candida glabrata","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2022.116749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116749"}}